Press Release
Press Release
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
According to a new report by EMR titled, ‘Global Emphysema Treatment Market Report and Forecast 2021-2026’, the global market for emphysema treatment is being aided by the growing chronic obstructive pulmonary disease treatment market, which is expected to grow at a CAGR of 4.8% between 2021 and 2026 to attain USD 24.7 billion by 2026.
The emphysema treatment industry is expected to be driven by the growing R&D activities to develop the novel treatment for emphysema. There has been a rise in the number of patients suffering from COPD and asthma in the past few years. The new approvals by the FDA for novel products and the increasing government initiatives to control COPD and asthma are significantly contributing to the market growth. The use of drugs, which has emerged as an effective solution to treat COPD and asthma, and their wide acceptance among the patients are, in turn, aiding the emphysema treatment industry growth.
Further, the expanding pharmaceutical industry in developing nations, such as China and India, provides huge growth opportunities for the market expansion. The introduction of generic drugs to this market is expected to further propel the industry growth in the coming years. Some of the leading players in the industry include Pulmonx Corp (NASDAQ: LUNG) and Pfizer Inc. (NYSE: PFE). In May 2021, Pulmonx announced that the company had secured USD 66 million in financing from Ally Bridge Group, a leading global life science investor, to support the commercial acceleration of the zephyr valve system, a minimally invasive treatment for severe emphysema. Such developments are expected to significantly aid the industry growth in the forecast period.
Market Breakup by Treatment, Types of Diseases, End Use, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global emphysema treatment market are Pulmonx Corporation, Kamada Limited, Pfizer Inc., and Uptake Medical Technology Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
About Us:
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Contact Us:
Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.